about
Why is coinfection with influenza virus and bacteria so difficult to control?Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.Strategies towards universal pandemic influenza vaccines.Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cellsInfluenza vaccines: challenges and solutions.Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccinationCombined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus.Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.Development of cross-protective influenza a vaccines based on cellular responses.Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases.Influenza infection in human host: challenges in making a better influenza vaccine.Application of replication-defective West Nile virus vector to non-flavivirus vaccine targets.Clinical Expectations for Better Influenza Virus Vaccines-Perspectives from the Young Investigators' Point of View
P2860
Q30371269-9807F9A6-0268-45E2-8A75-332F626EFD8EQ30375380-02C97A82-35F7-4C34-A2DB-F29D1BF506FCQ30382226-B616B6BD-9DA7-40C5-A42B-6DFBDD039B15Q35110853-38C728BD-4E8E-4B52-A93C-EF19E142DBBEQ35184572-E4084E03-820F-4114-88AC-C704E642200DQ35944742-565DD3DD-2086-4D4E-A8F0-BB1E19CEE6F7Q36369631-E0B37321-A264-4E54-A292-6B8D07800332Q36527796-CB693B09-B915-4C34-A9B6-660E565604B3Q38443390-8048AA51-DD12-4EF8-BE30-156C83FB72F0Q38510148-2DF736DA-3C77-4757-92EC-A8282E38AC11Q38559266-0419FD77-0DD0-4877-969A-2402ABCD6FC0Q38737075-E1DEE821-03B3-43A8-9D9A-27F45C8EC581Q41934776-8359A14B-EED9-4745-9D0D-B1746B208A27Q56536297-2EAFCB6A-7FAA-48B5-BFFB-8B93CFFBF752
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Virus-vectored influenza virus vaccines.
@ast
Virus-vectored influenza virus vaccines.
@en
Virus-vectored influenza virus vaccines.
@nl
type
label
Virus-vectored influenza virus vaccines.
@ast
Virus-vectored influenza virus vaccines.
@en
Virus-vectored influenza virus vaccines.
@nl
prefLabel
Virus-vectored influenza virus vaccines.
@ast
Virus-vectored influenza virus vaccines.
@en
Virus-vectored influenza virus vaccines.
@nl
P2860
P356
P1433
P1476
Virus-vectored influenza virus vaccines.
@en
P2093
Ralph A Tripp
P2860
P304
P356
10.3390/V6083055
P577
2014-08-07T00:00:00Z